Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
Abstract Schizophrenia (SZ) is a severe psychiatric disorder, with a prevalence of 1–2% world-wide and substantial health- and social care costs. The pathology is influenced by both genetic and environmental factors, however the underlying cause still remains elusive. SZ has symptoms including delus...
Main Authors: | Ugne Dubonyte, Andrea Asenjo-Martinez, Thomas Werge, Kasper Lage, Agnete Kirkeby |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Acta Neuropathologica Communications |
Online Access: | https://doi.org/10.1186/s40478-022-01460-2 |
Similar Items
-
Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
by: Ruhel Ahmad, et al.
Published: (2018-09-01) -
IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells
by: Daniela Lehnen, et al.
Published: (2017-10-01) -
The potential of induced pluripotent stem cell derived hepatocytes
by: Hannoun, Z, et al.
Published: (2016) -
Dental applications of induced pluripotent stem cells and their derivatives
by: Pan Gao, et al.
Published: (2022-11-01) -
Technical advances in pluripotent stem cell-derived and tumorigenic organoids
by: Suwon Kang, et al.
Published: (2022-08-01)